21 employees
Immuneoncia Therapeutics is an immuno-oncology-centric biopharmaceutical company.
2016
$40M
from 2 investors over 2 rounds
ImmuneOncia Therapeutics Inc. raised $20M on January 17, 2022
Investors: Premier Partners
ImmuneOncia Therapeutics Inc. raised $40M on February 12, 2019
Investors: Paratus Investment Inc.